IFNB1 and amyotrophic lateral sclerosis: Furthermore, these inhibitors are reported to have therapeutic benefits in mouse models of ALS driven by TDP-43 (Wang et al., 2016), and that is consistent with their anti-inflammatory effect when we examined expression of IFNB1 and TNF in ALS patient iPSC-derived motor neurons (Figure 3E).